von Willebrand Disease, Platelet Type (GP1BA) 3 Mutations (INACTIVE as of 11/15/21)
Molecular testing to distinguish von Willebrand disease (VWD) type 2B from pseudo (platelet-type) VWD.
Polymerase Chain Reaction/Sequencing
New York DOH Approval Status
Lavender (EDTA), pink (K2EDTA) or yellow (ACD Solution A or B).
Transport 2 mL whole blood. (Min: 1 mL)
Ambient: 7 days; Refrigerated: 1 month
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Counseling and informed consent are recommended for genetic testing. Consent forms are available online.
Laboratory Developed Test (LDT)
|Component Test Code*||Component Chart Name||LOINC|
|2005477||VWD Platelet Type (GP1BA) Seq Spcm|
|2005478||VWD PlatletType (GP1BA) Seq Interp|
- GP1BA Sequencing
- Platelet Type Von Willebrand Disease (vWD)
- Pseudo Von Willebrand Disease (vWD)
- Von Willebrand Disease (vWD) Platelet Type
- VWD Platelet Type 4